• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚美辛预防非骨水泥型髋关节置换术中异位骨化。一项对100例患者的前瞻性1年研究。

Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases.

作者信息

Wurnig C, Eyb R, Auersperg V

机构信息

Vienna University Department of Orthopedics, Allgemeines Krankenhaus, Austria.

出版信息

Acta Orthop Scand. 1992 Dec;63(6):628-30. doi: 10.1080/17453679209169723.

DOI:10.1080/17453679209169723
PMID:1471510
Abstract

In a prospective series of 100 patients we investigated the effect of indomethacin for 6 weeks in the prophylaxis of ectopic bone formation in hip replacements with cementless fixation. Indomethacin prophylaxis reduced (P < 0.0001) ectopic bone formation compared to a retrospective control group of equal size. Side-effects occurred in one-fifth of the patients, but most of these could continue the medication for at least 4 weeks.

摘要

在一项针对100例患者的前瞻性研究中,我们调查了吲哚美辛在非骨水泥固定髋关节置换术中预防异位骨形成的6周疗效。与同等规模的回顾性对照组相比,吲哚美辛预防措施减少了异位骨形成(P < 0.0001)。五分之一的患者出现了副作用,但其中大多数患者能够继续用药至少4周。

相似文献

1
Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases.吲哚美辛预防非骨水泥型髋关节置换术中异位骨化。一项对100例患者的前瞻性1年研究。
Acta Orthop Scand. 1992 Dec;63(6):628-30. doi: 10.1080/17453679209169723.
2
Indomethacin for prevention of ectopic ossification after hip arthroplasty.吲哚美辛预防髋关节置换术后异位骨化
Acta Orthop Scand. 1986 Feb;57(1):12-4. doi: 10.3109/17453678608993206.
3
Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen.全髋关节置换术后关节周围异位骨化的预防。吲哚美辛和布洛芬的临床经验。
Arch Orthop Trauma Surg (1978). 1988;107(6):329-33. doi: 10.1007/BF00381057.
4
Short term prophylaxis against heterotopic bone after cementless hip replacement.非骨水泥型髋关节置换术后异位骨形成的短期预防
Clin Orthop Relat Res. 1997 Jan(334):175-83.
5
Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.吲哚美辛预防异位骨化。41例髋关节置换术的随机对照研究。
Acta Orthop Scand. 1993 Dec;64(6):639-42. doi: 10.3109/17453679308994587.
6
Six-year results of a cementless stem with prophylaxis against heterotopic bone.一种预防异位骨化的非骨水泥型股骨柄假体的六年随访结果
Clin Orthop Relat Res. 1999 Apr(361):150-8. doi: 10.1097/00003086-199904000-00020.
7
[Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
Beitr Orthop Traumatol. 1990 Jun;37(6):330-4.
8
Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.吲哚美辛与美洛昔康预防全髋关节置换术后异位骨化的比较。
Arch Orthop Trauma Surg. 2003 Apr;123(2-3):91-4. doi: 10.1007/s00402-003-0487-y. Epub 2003 Mar 28.
9
[Periprosthetic ossification following total hip prosthesis. Risk factors--prevention using indomethacin].[全髋关节置换术后假体周围骨化。危险因素——使用吲哚美辛预防]
Rev Chir Orthop Reparatrice Appar Mot. 1987;73 Suppl 2:211-5.
10
Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
Acta Orthop Scand. 1998 Apr;69(2):107-10. doi: 10.3109/17453679809117607.

引用本文的文献

1
Aspirin decreases heterotopic ossification after hip resurfacing.阿司匹林可降低髋关节表面置换术后异位骨化。
Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.
2
Prevention of heterotopic ossification after total hip replacement with NSAIDs.非甾体抗炎药预防全髋关节置换术后异位骨化
Pharm World Sci. 2003 Aug;25(4):138-45. doi: 10.1023/a:1024830213832.
3
[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
[全髋关节置换术后异位骨化预防的前瞻性研究。非甾体类抗炎药与放射治疗的比较]
Strahlenther Onkol. 1997 Dec;173(12):677-82. doi: 10.1007/BF03038450.